Quantitative 1H Nuclear Magnetic Resonance Diffusion Spectroscopy of BT4C Rat Glioma during Thymidine Kinase-mediated Gene Therapy in Vivo: Identification of …

JM Hakumäki, H Poptani, AM Puumalainen, S Loimas… - Cancer research, 1998 - AACR
We have investigated the effects of thymidine kinase-mediated gene therapy in a malignant
rat BT4C glioma by using 1H nuclear magnetic resonance spectroscopy in vivo. Ganciclovir …
被引用次数：128 相关文章

Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of …

JM Hakumäki, H Poptani… - Cancer …, 1998 - pubmed.ncbi.nlm.nih.gov
We have investigated the effects of thymidine kinase-mediated gene therapy in a malignant
rat BT4C glioma by using 1H nuclear magnetic resonance spectroscopy in vivo. Ganciclovir …

[引用][C] Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: Identification of …

JM HAKUMÄKI, H POPTANI… - Cancer research …, 1998 - pascal-francis.inist.fr
Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during
thymidine kinase-mediated gene therapy in vivo : Identification of apoptotic response CNRS …

Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of …

JM Hakumäki, H Poptani, AM Puumalainen… - Cancer …, 1998 - europepmc.org
We have investigated the effects of thymidine kinase-mediated gene therapy in a malignant
rat BT4C glioma by using 1H nuclear magnetic resonance spectroscopy in vivo. Ganciclovir …

[引用][C] Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: Identification of …

JM HAKUMÄKI, H POPTANI… - Cancer …, 1998 - American Association for Cancer …